eprintid: 10174132
rev_number: 14
eprint_status: archive
userid: 699
dir: disk0/10/17/41/32
datestamp: 2023-07-27 11:05:36
lastmod: 2024-10-30 18:12:45
status_changed: 2023-07-27 11:05:36
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Pauling, John D
creators_name: Yu, Lan
creators_name: Frech, Tracy M
creators_name: Herrick, Ariane L
creators_name: Hummers, Laura K
creators_name: Shah, Ami A
creators_name: Denton, Christopher P
creators_name: Saketkoo, Lesley Ann
creators_name: Withey, Jane
creators_name: Khanna, Dinesh
creators_name: Domsic, Robyn T
title: Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) questionnaire
ispublished: pub
subjects: RFH
divisions: UCL
divisions: B02
divisions: C10
divisions: D17
divisions: G90
keywords: SSc, RP, patient-reported outcome instrument, clinical trial, validation
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
abstract: Objectives:
Assessment of construct validity and reliability of a novel patient-reported outcome (PRO) instrument for assessing the severity and impact of RP in SSc. /

Methods:
An international multicentre study validation study of the 27-item Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) and 10-item short-form (ASRAP-SF) questionnaires. The relationship between ASRAP questionnaires and demographics, clinical phenotype and legacy instruments for assessing SSc-RP severity, disability and pain was assessed. Repeatability was evaluated at 1 week. Anchor-based statements of health status facilitated assessment of ASRAP thresholds of meaning. /

Results:
A total of 420 SSc subjects were enrolled. There was good correlation between ASRAP (and ASRAP-SF) with RP visual analogue scale (VAS) and Scleroderma Health Assessment Questionnaire RP VAS (rho range 0.648–0.727, P < 0.001). Correlation with diary-based assessment of SSc-RP attack frequency and duration was lower (rho range 0.258–0.504, P < 0.001). ASRAP questionnaires had good correlation with instruments for assessing disability, hand function, pain and global health assessment (rho range 0.427–0.575, P < 0.001). Significantly higher ASRAP scores were identified in smokers, patients with active digital ulceration (DU), previous history of DU and calcinosis (P < 0.05 for all comparisons). There was excellent repeatability at 1 week among patients with stable SSc-RP symptoms (intra-class coefficients of 0.891 and 0.848, P < 0.001). Patient-acceptable symptom state thresholds for ASRAP and ASRAP-SF were 45.34 and 45.77, respectively. A preliminary Minimally Important Clinical Difference threshold of 4.17 (95% CI 0.53, 7.81, P = 0.029) was estimated. /

Conclusion:
ASRAP and ASRAP-SF questionnaires are valid and reliable novel PRO instruments for assessing the severity and impact of SSc-RP.
date: 2024-05
date_type: published
publisher: Oxford University Press (OUP)
official_url: https://doi.org/10.1093/rheumatology/kead371
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 2040013
doi: 10.1093/rheumatology/kead371
medium: Print-Electronic
pii: 7229563
lyricists_name: Denton, Christopher
lyricists_id: CPDEN87
actors_name: Denton, Christopher
actors_id: CPDEN87
actors_role: owner
full_text_status: public
publication: Rheumatology
volume: 63
number: 5
pagerange: 1281-1290
event_location: England
citation:        Pauling, John D;    Yu, Lan;    Frech, Tracy M;    Herrick, Ariane L;    Hummers, Laura K;    Shah, Ami A;    Denton, Christopher P;                 ... Domsic, Robyn T; + view all <#>        Pauling, John D;  Yu, Lan;  Frech, Tracy M;  Herrick, Ariane L;  Hummers, Laura K;  Shah, Ami A;  Denton, Christopher P;  Saketkoo, Lesley Ann;  Withey, Jane;  Khanna, Dinesh;  Domsic, Robyn T;   - view fewer <#>    (2024)    Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) questionnaire.                   Rheumatology , 63  (5)   pp. 1281-1290.    10.1093/rheumatology/kead371 <https://doi.org/10.1093/rheumatology%2Fkead371>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10174132/1/Construct%20validity%20and%20reliability%20of%20the%20ASRAP%20questionnaire_RHE-2023%20accepted%20with%20figs.pdf